Toronto | Canada
| Investor Type | Firm |
| Industries | BioTech • Medical Devices (& Hospital Services) • Robotics • Life Science • Oncology |
| Stages | Later |
| Investing | Canada |
| Investment Range | $2,000,000 - $61,500,000 |
About The Fund
Lumira Capital primarily invests in later stage biopharmaceutical companies typically having at least preliminary clinical proof of concept data and will also consider later stage medical device companies. The firm's history goes back to 1989 when the company was established as MDS Capital Corp. The company changed its name to Lumira Capital in September 2007 as part of a corporate repositioning to build on its strength in the North American health and life science sector. Typically, Lumira's initial investment size is $5 to 10 million, and the firm concentrates its investments in the U.S. and Canada.
Lumira Capital's investments on record
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
e
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 85 Great Portland St.
- London, U.K.
- contact@angelspartners.com
